You are viewing the site in preview mode
Skip to main content
|
Medical components
|
United States
|
Cost in USD (2013)
|
Medical components
|
India
|
Mexico
|
|---|
|
diagnostic & follow-up visits (quantity)a
|
Cost in USD (2013)b
|
Cost in USD (2013)b
|
|---|
|
Chest radiograph
|
3
|
$35.82
|
Panel physician screening exam
|
$26.46
|
$190
|
|
Sputum smears
|
5
|
$9.99
|
Chest radiograph
|
Included in exam fee, $6.00 for subsequent
|
Included in exam fee
|
|
Cultures
|
5
|
$20.07
|
Sputum smears
|
$32.68
|
Included in exam fee
|
|
Complete blood count with differential
|
3
|
$7.93
|
Cultures
|
$32.68
|
Included in exam fee
|
|
Serum chemistry
|
1
|
$15.71
|
Treatment at panel physician site
|
$79.40
|
Included in exam fee
|
|
Drug susceptibility tests
|
4
|
$10.50
|
Additional medical examsc
|
$259.00
|
Included in exam fee
|
|
Hepatic function panel
|
3
|
$15.17
|
Treatment at local healthcare site
|
60.00
|
Included in exam fee
|
- Notes: In the United States, each person with active tuberculosis receives three diagnostic visits and five follow-up visits. The costs for medical components were computed using the 2013 Physician Fee Schedule from the Centers for Medicare and Medicaid Services
- Diff differential
- aPersons with Class B1 TB designation do not receive all diagnostic and follow-up visits unless they are diagnosed with active tuberculosis
- bAll prices obtained from Indian and Mexican panel physicians and are presented in 2013 dollars. We estimated that 30% of the panel physician screening exam costs in India is attributable to TB, and 50% of the panel physician screening exam in Mexico costs is attributable to TB. Note that the higher fraction is assumed for Mexico, because, in India, culture/smear testing and treatment are charged separately only for applicants that need such services. Treatment at panel physician consists of the medication and directly observed therapy
- cAdditional medical exams means the total costs for additional smears, cultures, chest radiographs, drug susceptibility testing, and liver testing at panel physician sites